JPH035472A - Optically active compound and its production - Google Patents
Optically active compound and its productionInfo
- Publication number
- JPH035472A JPH035472A JP1140796A JP14079689A JPH035472A JP H035472 A JPH035472 A JP H035472A JP 1140796 A JP1140796 A JP 1140796A JP 14079689 A JP14079689 A JP 14079689A JP H035472 A JPH035472 A JP H035472A
- Authority
- JP
- Japan
- Prior art keywords
- group
- general formula
- optically active
- compound
- active compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 52
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 10
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 18
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 14
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 10
- 125000002252 acyl group Chemical group 0.000 claims abstract description 8
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 8
- 150000001340 alkali metals Chemical class 0.000 claims abstract description 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 8
- 125000003118 aryl group Chemical group 0.000 claims abstract description 6
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims abstract description 5
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 5
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 5
- 125000006239 protecting group Chemical group 0.000 claims abstract description 5
- 125000005842 heteroatom Chemical group 0.000 claims abstract description 4
- 239000000126 substance Substances 0.000 claims description 14
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 12
- 230000003287 optical effect Effects 0.000 claims description 12
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 claims description 5
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims description 3
- 150000004696 coordination complex Chemical class 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 24
- 230000015572 biosynthetic process Effects 0.000 abstract description 16
- 238000003786 synthesis reaction Methods 0.000 abstract description 16
- 150000003180 prostaglandins Chemical class 0.000 abstract description 11
- 239000002585 base Substances 0.000 abstract description 6
- 125000000457 gamma-lactone group Chemical group 0.000 abstract description 6
- 150000002366 halogen compounds Chemical class 0.000 abstract description 6
- 239000002994 raw material Substances 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 43
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 41
- -1 2-hexyl Chemical group 0.000 description 38
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 20
- 239000000203 mixture Substances 0.000 description 20
- 239000002904 solvent Substances 0.000 description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 16
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 239000000543 intermediate Substances 0.000 description 11
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 11
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 10
- 150000004808 allyl alcohols Chemical class 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- QWOJMRHUQHTCJG-UHFFFAOYSA-N CC([CH2-])=O Chemical compound CC([CH2-])=O QWOJMRHUQHTCJG-UHFFFAOYSA-N 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- QFXZANXYUCUTQH-UHFFFAOYSA-N ethynol Chemical class OC#C QFXZANXYUCUTQH-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- 238000010898 silica gel chromatography Methods 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- PPTSRTIIAOKIOL-AWEZNQCLSA-N (2s)-2-phenylmethoxyheptanal Chemical compound CCCCC[C@@H](C=O)OCC1=CC=CC=C1 PPTSRTIIAOKIOL-AWEZNQCLSA-N 0.000 description 7
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 7
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 7
- 150000002009 diols Chemical class 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical group O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 239000002841 Lewis acid Substances 0.000 description 4
- 239000003377 acid catalyst Substances 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 4
- 125000005843 halogen group Chemical group 0.000 description 4
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 150000007517 lewis acids Chemical class 0.000 description 4
- 235000010355 mannitol Nutrition 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- GIZSHQYTTBQKOQ-UHFFFAOYSA-N threo-Syringoylglycerol Chemical compound COC1=CC(C(O)C(O)CO)=CC(OC)=C1O GIZSHQYTTBQKOQ-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- HQQULPUXSRHOGE-UHFFFAOYSA-N 1,4-Pentadiyn-3-one Chemical class C#CC(=O)C#C HQQULPUXSRHOGE-UHFFFAOYSA-N 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000001308 synthesis method Methods 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 101150041968 CDC13 gene Proteins 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- LWLPYZUDBNFNAH-UHFFFAOYSA-M magnesium;butane;bromide Chemical compound [Mg+2].[Br-].CCC[CH2-] LWLPYZUDBNFNAH-UHFFFAOYSA-M 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000000967 suction filtration Methods 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- NDQXKKFRNOPRDW-UHFFFAOYSA-N 1,1,1-triethoxyethane Chemical compound CCOC(C)(OCC)OCC NDQXKKFRNOPRDW-UHFFFAOYSA-N 0.000 description 1
- HDPNBNXLBDFELL-UHFFFAOYSA-N 1,1,1-trimethoxyethane Chemical compound COC(C)(OC)OC HDPNBNXLBDFELL-UHFFFAOYSA-N 0.000 description 1
- UEVZIKFSVBYKAC-UHFFFAOYSA-N 1-(1,1-dibutoxyethoxy)butane Chemical compound CCCCOC(C)(OCCCC)OCCCC UEVZIKFSVBYKAC-UHFFFAOYSA-N 0.000 description 1
- DWLUIFLANBQDBR-UHFFFAOYSA-N 1-(1,1-diheptoxyethoxy)heptane Chemical compound C(C)(OCCCCCCC)(OCCCCCCC)OCCCCCCC DWLUIFLANBQDBR-UHFFFAOYSA-N 0.000 description 1
- JDQNNHFSSCEQPM-UHFFFAOYSA-N 1-(1,1-dipropoxyethoxy)propane Chemical compound CCCOC(C)(OCCC)OCCC JDQNNHFSSCEQPM-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 description 1
- 101100006370 Arabidopsis thaliana CHX2 gene Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 238000006568 Claisen-Johnson rearrangement reaction Methods 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical group O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- CTKINSOISVBQLD-UHFFFAOYSA-N Glycidol Chemical compound OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 description 1
- DJOWTWWHMWQATC-KYHIUUMWSA-N Karpoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1(O)C(C)(C)CC(O)CC1(C)O)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C DJOWTWWHMWQATC-KYHIUUMWSA-N 0.000 description 1
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 1
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical class FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- JEHCHYAKAXDFKV-UHFFFAOYSA-J lead tetraacetate Chemical compound CC(=O)O[Pb](OC(C)=O)(OC(C)=O)OC(C)=O JEHCHYAKAXDFKV-UHFFFAOYSA-J 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- ARNWQMJQALNBBV-UHFFFAOYSA-N lithium carbide Chemical compound [Li+].[Li+].[C-]#[C-] ARNWQMJQALNBBV-UHFFFAOYSA-N 0.000 description 1
- SIAPCJWMELPYOE-UHFFFAOYSA-N lithium hydride Chemical compound [LiH] SIAPCJWMELPYOE-UHFFFAOYSA-N 0.000 description 1
- 229910000103 lithium hydride Inorganic materials 0.000 description 1
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 1
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- DOHXSUFORRJRAO-UHFFFAOYSA-N methanesulfonyl chloride;pyridine Chemical compound CS(Cl)(=O)=O.C1=CC=NC=C1 DOHXSUFORRJRAO-UHFFFAOYSA-N 0.000 description 1
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- XHFLOLLMZOTPSM-UHFFFAOYSA-M sodium;hydrogen carbonate;hydrate Chemical class [OH-].[Na+].OC(O)=O XHFLOLLMZOTPSM-UHFFFAOYSA-M 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、G、 5torkらによって開発されたプロ
スタグランジン合成法(G、5tork、 丁、 T
akahash i 。DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a prostaglandin synthesis method developed by G. 5tork et al.
akahash i.
■、にawamoto、 T、5uzuki :J、A
m、Chem、Soc、、 100 。■, awamoto, T, 5uzuki: J, A
m, Chem, Soc,, 100.
8272 (1978) )における重要な中間体であ
る、下記一般式(P)
(上記一般式(P)において、R1はアルコキシ基を有
していてもよいアルキル基、シクロアルキル基及び芳香
環もしくはアルキル基にヘテロ原子を有するアラルキル
基から選ばれた炭素数1〜12の基、R2は水素原子又
はアシル基、シリル基、アラルキル基及びアルキルオキ
シアルキル基から選ばれた容易に脱離可能な保護基を表
わし、*の符号は不斉炭素原子を表わす)で表わされる
光学活性γ−ラクトン誘導体を製造するための中間体で
ある光学活性化合物及びその製法に関する。8272 (1978)) is an important intermediate in the following general formula (P) (In the above general formula (P), R1 is an alkyl group that may have an alkoxy group, a cycloalkyl group, an aromatic ring, or an alkyl group. A group having 1 to 12 carbon atoms selected from aralkyl groups having a heteroatom in the group, R2 is a hydrogen atom or an easily removable protecting group selected from acyl groups, silyl groups, aralkyl groups, and alkyloxyalkyl groups. The present invention relates to an optically active compound that is an intermediate for producing an optically active γ-lactone derivative represented by the formula (where * symbol represents an asymmetric carbon atom) and a method for producing the same.
(従来の技術及び解決すべき課題)
プロスタグランジンの製造に関しては、上記G、 5t
orkらの合成法の他に、コーリーラクトンや4−ヒド
ロキシシクロベンテノンより出発する方法が実用化され
ているが、この方法は原料の光学活性体を得るために光
学分割や微生物による不斉水解などの工程を経る必要が
おり、ざらにこれらを基にしてα、ω側鎖を導入してい
く段階での立体制御においても問題点が多い。このよう
な点からみると上記G、 5torkらにより開発され
た前記一般式(P)の光学活性γ−ラクトン誘導体を鍵
中間体とするプロスタグランジン合成法は優れた方法で
おるといえる。しかしながら、この方法における問題点
は鍵中間体となる一般式(P)の化合物をいかに経済的
に製造できるかにかかっていた。(Prior art and problems to be solved) Regarding the production of prostaglandin, the above G, 5t
In addition to the synthesis method of Ork et al., a method starting from Corey lactone or 4-hydroxycyclobentenone has been put into practical use, but this method requires optical resolution or asymmetric hydrolysis by microorganisms to obtain the optically active material. It is necessary to go through the following steps, and there are many problems in steric control at the stage of introducing α and ω side chains based on these steps. From this point of view, the method of synthesizing prostaglandins using the optically active γ-lactone derivative of general formula (P) as a key intermediate, developed by G. 5tork et al., can be said to be an excellent method. However, the problem with this method lies in how economically the compound of general formula (P), which serves as a key intermediate, can be produced.
(課題を解決するための手段)
本発明者らは、上記問題点を解決すべく鋭意検問の結果
、鍵中間体である上記一般式(P)で表わされる化合物
を従来より簡便に、且つ効率よく製造する方法を見出し
たものであり、本発明はこの製造の過程で得られる中間
体及びその製法を提供するものである。(Means for Solving the Problems) As a result of intensive investigation to solve the above problems, the present inventors have discovered that the compound represented by the above general formula (P), which is a key intermediate, can be produced more easily and efficiently than before. The present invention provides an intermediate obtained in the process of this production and a method for producing the same.
本発明は、下記一般式(A>
(上記一般式(A>において、R1はアルコキシ基を有
していてもよいアルキル基、シクロアルキル基及び芳香
環もしくはアルキル基にペテロ原子を有するアラルキル
基から選ばれた炭素数1〜12の基、R2は水素原子又
はアシル基、シリル基、アラルキル基及びアルキルオキ
シアルキル基から選ばれた容易に脱離可能な保護基を表
わし、*の符号は不斉炭素原子を表わす)で表わされる
光学活性化合物及びその製法でおる。The present invention is based on the following general formula (A> (In the above general formula (A>), R1 is an aralkyl group having a petero atom in an aromatic ring or alkyl group, a cycloalkyl group, an alkyl group that may have an alkoxy group, The selected group having 1 to 12 carbon atoms, R2 represents a hydrogen atom or an easily removable protecting group selected from an acyl group, a silyl group, an aralkyl group, and an alkyloxyalkyl group, and the symbol * represents an asymmetric (representing a carbon atom) and its production method.
上記一般式(A)におけるR1の具体例としては、メチ
ル、エチル、プロピル、イソプロピル。Specific examples of R1 in the above general formula (A) are methyl, ethyl, propyl, and isopropyl.
ブチル、イソブチル、ペンチル、イソペンチル。Butyl, isobutyl, pentyl, isopentyl.
22−ジメチルペンチル、r\キシル、2−ヘキシル、
ヘプチル、2−ヘプチル、オクチル、2−オクチル、ノ
ニル、2−ノニル、デシル、2−デシル、ウンデシル、
2−ウンデシル、ドデシル。22-dimethylpentyl, r\xyl, 2-hexyl,
heptyl, 2-heptyl, octyl, 2-octyl, nonyl, 2-nonyl, decyl, 2-decyl, undecyl,
2-Undecyl, dodecyl.
2−エトキシ−1,1−ジメチルエチル、5−メトキシ
シ1−メチルペンチル、シクロペンチル。2-ethoxy-1,1-dimethylethyl, 5-methoxy-1-methylpentyl, cyclopentyl.
3−エチルシクロペンチル、シクロヘキシル。3-Ethylcyclopentyl, cyclohexyl.
2−メチルシクロヘキシル、4−n−プロピルシクロヘ
キシルなどのアルコキシ置換基を有していてもよい直鎖
状もしくは分岐状アルキル基又はシクロアルキル基、フ
ェニルオキシメチル、3−トリフルオロメチルフェニル
オキシメチル、2−クロロチオフェン−5−イルオキシ
メチル、フラン−2−イル−2−エチルなどの芳香環も
しくはアルキル基にペテロ原子を有するアラルキル基が
挙げられる。Straight chain or branched alkyl group or cycloalkyl group optionally having an alkoxy substituent such as 2-methylcyclohexyl, 4-n-propylcyclohexyl, phenyloxymethyl, 3-trifluoromethylphenyloxymethyl, 2 -Chlorothiophen-5-yloxymethyl, furan-2-yl-2-ethyl, and other aralkyl groups having a petero atom in an aromatic ring or an alkyl group.
また一般式(A)における水素原子以外のR2の具体例
としては、ベンゾイル、アセチル、p−フェニルベンゾ
イルなどのアシル基、t−ブチルメチルシリル、トリメ
チルシリル、 t−ブチルジフェニルシリルなどのシリ
ル基、ベンジル、4−二トロフェニルメチルなどのアラ
ルキル基、テトラヒドロピラニル、1−エトキシエチル
などのフルキルオキシアルキル基等の容易に脱離可能な
基が挙げられる。Specific examples of R2 other than hydrogen atoms in general formula (A) include acyl groups such as benzoyl, acetyl, and p-phenylbenzoyl; silyl groups such as t-butylmethylsilyl, trimethylsilyl, and t-butyldiphenylsilyl; benzyl; , aralkyl groups such as 4-nitrophenylmethyl, and fluoroxyalkyl groups such as tetrahydropyranyl and 1-ethoxyethyl.
プロスタグランジンは生体内でプロスタグランジン合成
酵素によりアラキドン酸などの高級不飽和脂肪酸が化学
変換されて生じる極めて強い生理活性をもつ化合物で下
記のような構造を有している。Prostaglandins are compounds with extremely strong physiological activity that are produced by chemical conversion of higher unsaturated fatty acids such as arachidonic acid by prostaglandin synthase in vivo, and have the following structure.
OH
OH
GF
OH
GE
天然のプロスタグランジンでは、R1はn −C5H1
1−1Rは(CH2)e C0OH又はCH2CH=C
I−((CH2)3 C0OHで必り、R1の置換基は
脂溶性を有することが生理活性の発現上重要でおること
が知られている。医薬品としての開発研究が進められる
中でざらにR1としてアルキル基、シクロアルキル基又
はアラルキル基であって炭素数4〜10のものが有効で
あり、例えばペンデル、イソペンチル、2,2−ジメチ
ルペンデル、ヘキシル、2−ヘキシル、ヘプチル、2−
エトキシ−1,1−ジメチルエチル、5−メトキシ−1
−メチルペンチルなどのアルキル基、シクロペンチル、
3−エチルシクロペンチル、4−プロピルシクロヘキシ
ルなどのシクロアルキル基、フェニルオキシメチル、
3−トリフルオロメチルフェニルオキシメチル、2−ク
ロロチオフェン5−イルオキシメチル、フラン−2−イ
ル−2−エチルなどのアラルキル基などが特に強い生理
活性を示すことが明らかにされてきた。本発明の化合物
はこれら有機基を含めた置換基を導入することのできる
原料として有用なものである。OH OH GF OH GE In natural prostaglandins, R1 is n -C5H1
1-1R is (CH2)e C0OH or CH2CH=C
It is known that in I-((CH2)3C0OH, it is important for the R1 substituent to be lipophilic for the expression of physiological activity. As R1, an alkyl group, a cycloalkyl group, or an aralkyl group having 4 to 10 carbon atoms is effective, such as pendel, isopentyl, 2,2-dimethylpendel, hexyl, 2-hexyl, heptyl, 2-
Ethoxy-1,1-dimethylethyl, 5-methoxy-1
-Alkyl groups such as methylpentyl, cyclopentyl,
Cycloalkyl groups such as 3-ethylcyclopentyl and 4-propylcyclohexyl, phenyloxymethyl,
It has been revealed that aralkyl groups such as 3-trifluoromethylphenyloxymethyl, 2-chlorothiophen-5-yloxymethyl, and furan-2-yl-2-ethyl exhibit particularly strong physiological activity. The compounds of the present invention are useful as raw materials into which substituents including these organic groups can be introduced.
本発明の上記一般式(A>で表わされるエヂニルアルコ
ール誘導体の合成法を以下合成経路■に従って説明する
。下記において、Xはハロゲン原子、Mはアルカリ金属
を表わす。The method for synthesizing the edinyl alcohol derivative represented by the above general formula (A>) of the present invention will be explained below according to synthetic route (2). In the following, X represents a halogen atom and M represents an alkali metal.
(2′ )
(4)
(1)
(2)
(B)
上記反応において、ハロゲン化合物(1)にn−ブチル
リチウム、 t−ブチルリチウム、メチルリチウム、リ
チウムジイソプロピルアミドなどの強塩基を作用させて
アセチレン化合物(2)とし、さらにこれらの強塩基に
よりアルカリ金属アセチリド(2′)とする。これに光
学活性アルデヒド(3)を作用させると化合物(4)が
得られる。(2') (4) (1) (2) (B) In the above reaction, the halogen compound (1) is reacted with a strong base such as n-butyllithium, t-butyllithium, methyllithium, lithium diisopropylamide, etc. An acetylene compound (2) is obtained, and then an alkali metal acetylide (2') is obtained by using these strong bases. Compound (4) is obtained by reacting optically active aldehyde (3) with this.
上記アルカリ金属アセチリド(2′)は、上記のように
アセチレン化合物(2)を−度中離して再度強塩基と反
応させて調製してもよいが、より簡便にはハロゲン化合
物(1)を2倍量以上の強塩基と反応させて得られるア
ルカリ金属アセチリドをそのまま用いることができる。The alkali metal acetylide (2') may be prepared by neutralizing the acetylene compound (2) as described above and reacting it again with a strong base, but more simply, the halogen compound (1) can be prepared by Alkali metal acetylides obtained by reacting with twice or more of a strong base can be used as they are.
このアルカリ金属アセチリドと光学活性アルデヒド〈3
)との反応は一78〜O℃の低温で行うことが望ましい
。This alkali metal acetylide and optically active aldehyde <3
) is preferably carried out at a low temperature of -78°C to 0°C.
化合物(4)を得る反応はテトラヒドロフラン。The reaction to obtain compound (4) is tetrahydrofuran.
ジイソプロピルエーテル、トルエンなどの不活性溶媒中
−78℃〜室温の温度範囲で行うことができる。この反
応によって得られる化合物(4)は下記化学式で示され
るようにエリトロ体(A−1>とトレオ体(A−2>の
混合物である。It can be carried out in an inert solvent such as diisopropyl ether or toluene at a temperature range of -78°C to room temperature. Compound (4) obtained by this reaction is a mixture of erythro form (A-1> and threo form (A-2>) as shown by the chemical formula below.
OH
この混合物からエリトロ体(A−1>又はトレオ体(A
−2)を選択的に得るにはカラム分離などによって分割
することができるが、後述するような化学的方法によっ
て簡便に、しかもより選択的にそれぞれの光学異性体を
製造することができる。この化合物(4)に酸化剤、例
えばCrO3−ピリジン、ジメチルスルホキシド(DM
SO)−酸ハライドなどを用いて酸化することにより化
合物<8>のエチニルケトン誘導体を得ることができる
。OH From this mixture, erythro form (A-1>) or threo form (A-1>
-2) can be obtained selectively by separation using column separation or the like, but each optical isomer can be easily and more selectively produced by a chemical method as described below. Add an oxidizing agent to this compound (4), such as CrO3-pyridine, dimethyl sulfoxide (DM
The ethynyl ketone derivative of compound <8> can be obtained by oxidation using SO)-acid halide or the like.
この化合物(B)より本発明の目的化合物である光学活
性エチニルアルコール誘導体(A>を合成する反応は、
jqようとするエチニルアルコール誘導体(A>が前記
化学式で示したエリトロ体(A−’I)であるか、また
はトレオ体(A−2>であるかによって反応条件が異な
る。即ち、エリトロ体(A−1>を目的とする場合は化
合物(B)を水素化ホウ素亜鉛錯体(Zn (Bt−1
a ) 2 >で、またトレオ体(A−2)を目的とす
る場合はアルカリ金属セレクトリド、例えばカリウムセ
レクトリドで還元することにより良好な選択性をもって
目的とする立体配置のエチニルアルコール誘導体(A>
を得ることができる。The reaction for synthesizing the optically active ethynyl alcohol derivative (A>, which is the target compound of the present invention) from this compound (B) is as follows:
The reaction conditions differ depending on whether the ethynyl alcohol derivative (A> shown in the above chemical formula) is the erythro form (A-'I) or the threo form (A-2>). A-1>, the compound (B) is a borohydride zinc complex (Zn (Bt-1
a) When the threo form (A-2) is desired, the ethynyl alcohol derivative (A-2) of the desired configuration can be obtained with good selectivity by reduction with an alkali metal selectride, such as potassium selectride. >
can be obtained.
上記反応における出発物質であるハロゲン化合物く1)
は、D−マンニトールや光学活性グリシドールから公知
の方法で得られる光学活性2,3−0−イソプロピリデ
ングリセルアルデヒドをトリフェニルホスフィン及びテ
トラハロメタンと反応させることにより容易に合成でき
る。Halogen compound which is the starting material in the above reaction 1)
can be easily synthesized by reacting optically active 2,3-0-isopropylidene glyceraldehyde obtained from D-mannitol or optically active glycidol by a known method with triphenylphosphine and tetrahalomethane.
また、上記光学活性アルデヒド(3)は、下記合成経路
■に従って合成することができる。下記において、R1
、R2及び*の符号は一般式(△)のR1、R2及び*
の符号と同様の意味を表わし、X、Yは、それぞれ独立
して水酸基、アシル基。Further, the above-mentioned optically active aldehyde (3) can be synthesized according to the following synthetic route (2). In the following, R1
, R2 and * signs are R1, R2 and * of general formula (△)
, and X and Y each independently represent a hydroxyl group or an acyl group.
スルホキシ基及びハロゲン原子から選ばれた基又は原子
を表わす。Represents a group or atom selected from a sulfoxy group and a halogen atom.
(C)
(a)
(d)
(b)
(e)
(f)
(3)
上記光学活性マンニトールをアセトンと酸触媒の存在下
で反応させてトリアセトニド(a>とし、これを含水酢
酸で部分加水分解してテトラオール(b)とし、これの
−級水酸基及び二級水酸基を各々別個にトリフェニルホ
スフィン−CCf’4.酸ハライド−ピリジン、ピリジ
ン−メタンスルホニルクロリドなどで選択的にアシル基
、スルホキシ基又はハロゲン原子で一部又は全部を変換
してアセトニド(C)とする。次いでこのアセトニド(
C)を塩基でジエポキシド(d>とした後、R3MgB
r、R3MgBr−Cu2 (CN)2゜R3Li(
但し、R3はR1より炭素数が1個少ない基を表わす)
や水素化リチ「クムアルミニウムなどでR1基を導入し
、さらに水酸基をR2X’(X’ はハロゲン原子又は
スルホキシ基)と反応させてアセトニド(e)とし、こ
れを加水分解してジオール(f)とした後、Pb (O
Ac) 4やN、aIOaなどで酸化して目的の光学活
性アルデヒド(3)を得ることができる。(C) (a) (d) (b) (e) (f) (3) The above optically active mannitol is reacted with acetone in the presence of an acid catalyst to form triacetonide (a>), which is partially hydrated with hydrous acetic acid. The tetraol (b) is decomposed, and its -class hydroxyl group and secondary hydroxyl group are selectively converted into acyl groups and sulfoxy groups with triphenylphosphine-CCf'4.acid halide-pyridine, pyridine-methanesulfonyl chloride, etc. Acetonide (C) is obtained by converting part or all of it with a group or a halogen atom.Then, this acetonide (C) is converted into acetonide (C).
After converting C) to diepoxide (d>) with a base, R3MgB
r, R3MgBr-Cu2 (CN)2゜R3Li(
However, R3 represents a group with one less carbon number than R1)
or lithium hydride, introduces R1 group with cumaluminum, etc., and further reacts the hydroxyl group with R2X'(X' is a halogen atom or sulfoxy group) to form acetonide (e), which is hydrolyzed to form diol (f). After that, Pb (O
The desired optically active aldehyde (3) can be obtained by oxidation with Ac) 4, N, aIOa, etc.
上記1qられた本発明の目的物である一般式(A>で表
わされる光学活性エチニルアルコール誘導体は、下記合
成経路■に従って化合物(6)であるγ−不飽和カルボ
ン酸誘導体に変換し、次いでプロスタグランジン合成に
おける鍵中間体である化合物(P)のγ−ラクトン誘導
体に変換することができる。下記において、R4は炭素
数1〜5の低扱アルキル基を表わす。The optically active ethynyl alcohol derivative represented by the general formula (A>), which is the object of the present invention and is the objective product of the present invention, is converted into a γ-unsaturated carboxylic acid derivative, which is the compound (6), according to the following synthetic route Compound (P), which is a key intermediate in grandin synthesis, can be converted into a γ-lactone derivative.In the following, R4 represents a low-strength alkyl group having 1 to 5 carbon atoms.
<A>
(5)
(6)
(P)
上記反応において、エチニルアルコール誘導体(A)は
水素化リチウムアルミニウム等で三重結合をトランス二
重結合へ還元してアリルアルコール誘導体(5)へ導か
れる。この反応はテトラヒドロフラン、ジオキサン等の
不活性溶媒中40〜80°Cの温度で行うことができる
。アリルアルコール誘導体(5)は、これをオルト酢酸
トリアルキルと共に酸触媒の存在下で加熱反応させ、ジ
ョンソン−クライゼン転位反応を行ってγ−不飽和カル
ボン酸誘導体(6)に変換される。用いるオルト酢酸ト
リアルキルとしてはオルト酢酸トリメチル。<A> (5) (6) (P) In the above reaction, the ethynyl alcohol derivative (A) is led to the allyl alcohol derivative (5) by reducing the triple bond to a trans double bond with lithium aluminum hydride or the like. This reaction can be carried out in an inert solvent such as tetrahydrofuran or dioxane at a temperature of 40 to 80°C. The allyl alcohol derivative (5) is converted into the γ-unsaturated carboxylic acid derivative (6) by subjecting it to a heating reaction with trialkyl orthoacetate in the presence of an acid catalyst to perform a Johnson-Claisen rearrangement reaction. The trialkyl orthoacetate used is trimethyl orthoacetate.
オルト酢酸トリエチル、オルト酢酸トリプロピル。Triethyl orthoacetate, tripropyl orthoacetate.
オルト酢酸トリブチル、オルト酢酸トリヘプチル等が挙
げられ、これをアリルアルコール誘導体(5)に対して
2〜10倍当量用い、トルエン、キシレン、メシチレン
等の溶媒中130〜180’Cの温度で反応が行われる
。酸触媒としてはルイス酸、ルイス酸錯体(例えばBF
3・(C2H5) 20)やヘプタン酸などの有機酸が
用いられる。このようにして得られたγ−不飽和カルボ
ンLX導体(6)のアセトニドを酸触媒で開環させ、分
子内ラクトン化させるとプロスタグランジン合成におけ
る鍵中間体でおる一般式(P)で表わされる光学活性γ
−ラクトン誘導体が得られる。この反応におけるアセト
ニドの加水分解は含水有機酸、メタノール、エタノール
等のアルコール、アセトン又はジオキサンなどの溶媒中
鉱酸やBF3 ・エーテル錯体、Cu5Oa、Zn5O
a等のルイス酸又はルイス酸錯体を用いて室温〜80’
Cの温度で行うことができる。Examples include tributyl orthoacetate, triheptyl orthoacetate, etc., and the reaction is carried out at a temperature of 130 to 180'C in a solvent such as toluene, xylene, mesitylene, etc. using 2 to 10 times equivalent amount to the allyl alcohol derivative (5). be exposed. As acid catalysts, Lewis acids, Lewis acid complexes (for example, BF
Organic acids such as 3.(C2H5) 20) and heptanoic acid are used. When the acetonide of the γ-unsaturated carboxylic LX conductor (6) thus obtained is ring-opened with an acid catalyst and intramolecularly lactonized, it is expressed by the general formula (P), which is a key intermediate in prostaglandin synthesis. Optical activity γ
-Lactone derivatives are obtained. Hydrolysis of acetonide in this reaction can be carried out using hydrous organic acids, alcohols such as methanol or ethanol, mineral acids in solvents such as acetone or dioxane, BF3/ether complexes, Cu5Oa, Zn5O, etc.
Using a Lewis acid or a Lewis acid complex such as a, room temperature to 80'
It can be carried out at a temperature of C.
このようにして得られた一般式(P)の化合物は、前記
G、 5tarkらのプロスタグランジン合成法に従っ
てプロスタグランジン(前記PGE、PGF)に導くこ
とができる。従って本発明における一般式(A>の光学
活性化合物は、上記原料としては一般式(A>中の2位
及び6位の立体配置は共にSであり、5位の立体配置が
Rでおることが必要とされる。The compound of general formula (P) thus obtained can be converted into prostaglandin (the above-mentioned PGE, PGF) according to the prostaglandin synthesis method of G. Tark et al. Therefore, in the present invention, the optically active compound of the general formula (A>) has the general formula (A> in which both the 2nd and 6th positions are S, and the 5th position is R. is required.
以下実施例によって本発明を説明する。The present invention will be explained below with reference to Examples.
(実 施 例)
実施例
〈化合物(a)の合成〉
45gのD−マンニトールをアセトン1.12及び濃塩
酸1d中で至湿下3日間激しく撹拌した後、炭酸カリウ
ム50fJを加え、ざらに1日撹拌した。固形物を吸引
濾過して除き、濾液中の溶媒を減圧下に沼ムし、得られ
た残漬に水を加え、析出した結晶を吸引濾取して粗生成
物45Clを19だ。これをエタノール20rIdlに
加熱溶解した後濾過し、濾液を室温に冷却して析出した
結晶を線取し、下記化学式で示される光学活性(2R,
3R,4R,5R)体のトリアセトニド(a) 37
.3g(収率50%)を得た。(Example) Example <Synthesis of compound (a)> 45 g of D-mannitol was vigorously stirred in 1.12 g of acetone and 1 d of concentrated hydrochloric acid under extremely humid conditions for 3 days, and then 50 fJ of potassium carbonate was added, Stir for days. The solid matter was removed by suction filtration, the solvent in the filtrate was evaporated under reduced pressure, water was added to the resulting residue, and the precipitated crystals were collected by suction filtration to obtain 45 Cl of the crude product. After heating and dissolving this in 20 rIdl of ethanol, it was filtered, and the filtrate was cooled to room temperature and the precipitated crystals were traced, and the optical activity (2R,
3R,4R,5R) triacetonide (a) 37
.. 3 g (yield 50%) was obtained.
18NMR(Cα4)
δ:1.40 (6H,S、 CH3X2 >1
.43 (12H,S、 CH3X4 )3.7
〜4.4 (8H,m、CH2、CH)〈化合物(b
)の合成〉
上記得られたトリアセトニド(a) 150(0,0
5mol)ラフ0%酢[507中40℃テ3.5時間撹
拌シタ後、40℃で出来丈速やかに減圧濃縮し、残漬に
アセトンを加え結晶化したD−マンニトール(0,72
(J)を濾別し、濾液よりアセトンを減圧留去してシロ
ップ状の生成物を得た。これをベンゼン50mで再結晶
して下記化学式で示される光学活性(2R,3R,4R
,5R)体のテトラオール(b)8.8(J(収率80
%)を得た。18NMR (Cα4) δ: 1.40 (6H,S, CH3X2 >1
.. 43 (12H,S, CH3X4)3.7
~4.4 (8H,m,CH2,CH)〈Compound (b
) Synthesis of triacetonide (a) 150 (0,0
After stirring for 3.5 hours at 40°C in rough 0% vinegar [507, it was immediately concentrated under reduced pressure at 40°C, and acetone was added to the residue to crystallize D-mannitol (0,72
(J) was filtered off, and acetone was distilled off from the filtrate under reduced pressure to obtain a syrup-like product. This was recrystallized with 50m of benzene to give an optical activity (2R, 3R, 4R) shown by the chemical formula below.
, 5R) tetraol (b) 8.8(J (yield 80
%) was obtained.
1HNMR(C20)
δ:1.38 < 6H,S、 CH3X2 )
3.3〜4.2 (8H,m、CH2,CH)く化合
物(C)及び(d)の合成〉
上記得られたテトラオール(b) 15.3g<0.
069m0+> 、無水ピリジン55m (0,68m
ol )、CH2Cf125(7の溶液中に、−70°
Cで塩化ベンゾイルled (0,138m01> 、
無水CH2(J25mの混合液を15分間かけて滴下し
、滴下後更に一30’Cで1時間、室温で10時間撹拌
し、反応の完結を薄層クロマトグラフで確認した後溶媒
を減圧留去した。1HNMR (C20) δ: 1.38 < 6H,S, CH3X2)
3.3-4.2 (8H, m, CH2, CH) Synthesis of compounds (C) and (d)> Tetrol (b) obtained above 15.3 g<0.
069m0+>, anhydrous pyridine 55m (0,68m
ol), CH2Cf125 (70°) in a solution of
Benzoyl chloride (0,138m01>,
A mixed solution of anhydrous CH2 (J25m) was added dropwise over 15 minutes, and after the dropwise addition, the mixture was further stirred at -30'C for 1 hour and at room temperature for 10 hours. After confirming the completion of the reaction by thin layer chromatography, the solvent was distilled off under reduced pressure. did.
この残漬にメタンスルホニルクロリド11.2m1(0
,144mof)を0℃で20分間かけて加え、更にこ
の懸濁液を室温で3日間撹拌した。反応の完結を薄層ク
ロマトグラフで確認した1麦、反応混合物にエチルエー
テル:ヘキサン=7:3(容量)の混合溶媒100dを
加え、この黄色の懸濁液をセライト−545で濾過し、
溶媒を減圧留去した。得られた褐色の残渣をCH202
2で希釈し、濃塩酸を加えて酸性にしだ後CH2α2で
3回抽出した。抽出物を飽和重曹水、飽和食塩水で順次
洗浄した後無水硫酸マグネシウムで乾燥し、溶媒を減圧
留去して下記化学式で示される光学活性(2R,3R,
4R。To this residue, 11.2 ml of methanesulfonyl chloride (0
, 144 mof) was added over 20 minutes at 0°C, and the suspension was further stirred at room temperature for 3 days. Completion of the reaction was confirmed by thin layer chromatography, and 100 d of a mixed solvent of ethyl ether:hexane = 7:3 (volume) was added to the reaction mixture, and this yellow suspension was filtered through Celite-545.
The solvent was removed under reduced pressure. The obtained brown residue was dissolved in CH202
The mixture was diluted with 2 and acidified with concentrated hydrochloric acid, and then extracted three times with CH2α2. The extract was washed successively with saturated aqueous sodium bicarbonate and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain optically active compounds (2R, 3R,
4R.
5R>体の褐色半固体物アセトニド(c) 42gを
得をセライト−545を通して濾過し、濾液を40℃で
減圧濃縮し、エチルエーテル:ヘキサン=7:3(各桁
)の混合溶媒3Mを加えて再度セライト−545で濾過
し、溶媒を40℃で減圧留去し、ざらに減圧蒸留により
粗生成物を得た。これをさらにベンゼンで再結晶して純
粋な下記化学式で示される光学活性(2S、 3R,4
R,53)体のジエポキシド(d>2.71収率21%
)を得た。42 g of acetonide (c), a brown semi-solid substance of 5R> body, was filtered through Celite-545, the filtrate was concentrated under reduced pressure at 40°C, and 3M of a mixed solvent of ethyl ether:hexane = 7:3 (each digit) was added. The mixture was filtered again through Celite-545, the solvent was distilled off under reduced pressure at 40°C, and a crude product was obtained by distillation under reduced pressure. This is further recrystallized from benzene to obtain pure optical activity (2S, 3R, 4
R, 53) diepoxide (d>2.71 yield 21%
) was obtained.
(C)
(但し、MSはメチルスルホキシ基、phは)工二ル基
を表わす)
上記アセトニド(C) 42(]、 K2 GO32
0gをメタノール130m1中で15時間撹拌した後、
反応液’HNMR(CDCb )
δ:1.39 (6H。(C) (However, MS represents a methylsulfoxy group, and pH represents an engineering group) The above acetonide (C) 42(], K2 GO32
After stirring 0 g in 130 ml of methanol for 15 hours,
Reaction solution 'HNMR (CDCb) δ: 1.39 (6H.
2.6〜2.9 < 48゜ 2.95〜3.12 (2H。2.6~2.9 < 48゜ 2.95-3.12 (2H.
3.7〜3.95 (2H。3.7-3.95 (2H.
CH3X2 )
CH2X2 )
CH)
CH)
〈化合物(e)及び(f)の合成〉
Cu2 (CN)2 320mg、無水テトラヒドロ
フラン100dの混合物に、別途調製した濃度1.47
molのn−ブチルマグネシウムプロミドのエーテル溶
液64m (94m mol >を0°Cで5分間かけ
てh口えた。ざらに5分間撹拌した後、上記得られたジ
エボキシド(d) 6.48(]の無水テトラヒドロ
フラン507溶液を0℃で撹拌下10分間かけて滴下し
、ざらに1時間撹拌した。反応の完結を薄層クロマトグ
ラフで確認した後、NHaαと飽和食塩水で分解し、3
0分間撹拌後、エチルエーテルで3回抽出し、エーテル
層を1規定塩酸、飽和重曹水、飽和食塩水で順次洗浄し
、無水@酸マグネシウムで乾燥して濾過し、濾液の溶媒
を留去して下記化学式で示される光学活性(68,7R
,8R,9S)体の粗ジオール(e−1>を得た。CH3X2 ) CH2X2 ) CH) CH) <Synthesis of compounds (e) and (f)> A separately prepared concentration of 1.47 was added to a mixture of 320 mg of Cu2 (CN)2 and 100 d of anhydrous tetrahydrofuran.
64 m (94 m mol) of an ether solution of n-butylmagnesium bromide was sipped at 0°C over 5 minutes. After roughly stirring for 5 minutes, the dieboxide (d) obtained above was mixed with 6.48 m (94 m mol) of n-butylmagnesium bromide. A solution of anhydrous tetrahydrofuran 507 was added dropwise at 0°C over 10 minutes with stirring, and the mixture was roughly stirred for 1 hour. After confirming the completion of the reaction by thin layer chromatography, the solution was decomposed with NHaα and saturated saline, and 3
After stirring for 0 minutes, the mixture was extracted three times with ethyl ether, and the ether layer was washed successively with 1N hydrochloric acid, saturated aqueous sodium bicarbonate, and saturated brine, dried over anhydrous magnesium chloride, filtered, and the solvent of the filtrate was distilled off. The optical activity (68,7R
, 8R, 9S) crude diol (e-1>) was obtained.
上記得られた粗ジオール(e−1>を無水テトラヒドロ
フラン30dに溶かし、これに水素化ナトリウム0.4
ag(1,07m mol)の無水テトラヒドロフラン
100dを還流下15分間かけて滴下し、ざらに1時間
撹拌還流した後O℃に冷却した。この懸濁液にDC−1
8−クラウンエーテル−6132mgと臭化ベンジル9
.3m (78m mol >をO′Cで加えて4時間
撹拌還流した。反応液を減圧濃縮し、1規定塩酸で分解
した後ヘキサンで3回抽出し、抽出液を飽和重曹水、飽
和食塩水で洗浄し、無水硫酸マグネシウムで乾燥した後
溶媒を減圧留去して下記化学式で示される光学活性(6
3,7R,8R,9S)体のアセトニド(e−2>を得
た。The crude diol (e-1> obtained above was dissolved in 30 d of anhydrous tetrahydrofuran, and 0.4 d of sodium hydride was added to the solution.
100 d of anhydrous tetrahydrofuran (1.07 mmol) was added dropwise to the mixture over 15 minutes under reflux, and the mixture was roughly stirred and refluxed for 1 hour, and then cooled to 0°C. DC-1 to this suspension
8-crown ether-6132 mg and benzyl bromide 9
.. 3 m (78 mmol) was added with O'C and stirred and refluxed for 4 hours. The reaction solution was concentrated under reduced pressure, decomposed with 1N hydrochloric acid, extracted three times with hexane, and the extract was diluted with saturated aqueous sodium bicarbonate and saturated brine. After washing and drying over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure to obtain the optical activity (6
3,7R,8R,9S) acetonide (e-2>) was obtained.
(但し、3nはベンジル基を表わす)
上記アセトニド(e−2>を80%酢1100d中10
0’Cで10時間加熱撹拌した後、溶媒を減圧留去し、
次いでエチルエーテルで抽出し、抽出液を苛性ソーダ水
溶液で洗浄し、水層はざらにエチルエーテルで抽出し、
これらエーテル層を併せて1規定塩酸、飽和重曹水、食
塩水で順次洗浄して無水硫酸マグネシウムで乾燥した。(However, 3n represents a benzyl group) The above acetonide (e-2>
After heating and stirring at 0'C for 10 hours, the solvent was distilled off under reduced pressure.
Next, it was extracted with ethyl ether, the extract was washed with an aqueous solution of caustic soda, and the aqueous layer was roughly extracted with ethyl ether.
These ether layers were combined, washed successively with 1N hydrochloric acid, saturated sodium bicarbonate solution, and brine, and dried over anhydrous magnesium sulfate.
溶媒を留去後シリカゲル−カラムクロマトグラフィーで
精製しくエチルエーテル:ヘキサン=1:4(容量)で
溶出)、下記化学式で示される光学活性(63,7R,
8R,93)体のジオール(f)8.66g(化合物(
d)よりの収率55%)を得た。After distilling off the solvent, it was purified by silica gel column chromatography, eluted with ethyl ether:hexane = 1:4 (volume)), and the optical activity represented by the following chemical formula (63,7R,
8R,93) diol (f) 8.66 g (compound (
d) with a yield of 55%).
(但し、Bnはベンジル基を表わす)
’HNMR(CDCI23 )
δ:O,138(6H,br、CH3X2 >1.0〜
1.8 (16H,m、 CH2X8 )3.4〜3
.7 (4H,m、CH)4.46 (2H,
d、 J=10.81(z、 0H)4.62
(2H,d、 J=10.8Hz、 CH)7.30
(IOH,S、 Ca Hs )〈化合物(3)
の合成〉
上記得られたジオール(f) 200mg。(However, Bn represents a benzyl group) 'HNMR (CDCI23) δ: O, 138 (6H, br, CH3X2 >1.0~
1.8 (16H, m, CH2X8) 3.4~3
.. 7 (4H, m, CH) 4.46 (2H,
d, J=10.81(z, 0H)4.62
(2H, d, J=10.8Hz, CH)7.30
(IOH,S, CaHs)〈Compound (3)
Synthesis> 200 mg of the diol (f) obtained above.
K2 CO360mg及び無水ベンゼン4.5d中に四
酢酸鉛260mgを4℃で加えて3分間撹拌した。反応
終了後ヘキサン1G0r111を加え、セライト−54
5を用いて濾過し、濾液を飽和重曹水で洗浄し、水層を
ヘキサンで2回抽出し、ヘキサン層を併せて飽和食塩水
で洗浄した後無水硫酸マグネシウムで乾燥した。溶媒を
留去後、シリカゲルカラムクロマトグラフィー(エチル
エーテル:ヘキサン=1:2 (容量))で精製して(
S)−2−ベンジルオキシヘプタナール(3) 16
0mg(収率80%)を得た。260 mg of lead tetraacetate was added to 360 mg of K2CO and 4.5 d of anhydrous benzene at 4°C, and the mixture was stirred for 3 minutes. After the reaction is complete, add 1G0r111 of hexane and add Celite-54.
5, the filtrate was washed with saturated aqueous sodium bicarbonate, the aqueous layer was extracted twice with hexane, the hexane layers were combined, washed with saturated brine, and then dried over anhydrous magnesium sulfate. After distilling off the solvent, it was purified by silica gel column chromatography (ethyl ether:hexane=1:2 (volume)) to obtain (
S)-2-benzyloxyheptanal (3) 16
0 mg (yield 80%) was obtained.
(但し、Bnはベンジル基を表わす)
’HNMR(CDCJlx )
δ:0.87 (3H,t、 J= 5.8Hz
。(However, Bn represents a benzyl group) 'HNMR (CDCJlx) δ: 0.87 (3H, t, J = 5.8Hz
.
CH3>
1.0〜1.8 (8H,’m、 CH2)3.73
(IH,dt、 J= 2.2Hz。CH3> 1.0~1.8 (8H,'m, CH2) 3.73
(IH, dt, J = 2.2Hz.
6.2H1,CH)
4.51 (IH,d、 J=11.6NZ、
CH)4.65 (1t−f、 d、 J=11
.6Hz、 CH)7.34 (5H,S、Ca
Hs)9.64 (IH,d、 J= 2.2
Hz)〈化合物(4)の合成〉
下記化学式(1〉
で表わされる(S)−ジブロマイド4.8(1(16,
8mmol)の無水テトラヒドロフラン100mを一7
8℃に冷却し、窒素雰囲気下で濃度1.62molのブ
チルリチウム−ヘキサン溶液16.4m (26,6m
mol>を10分間かけて滴下し、−78℃でざらに
1時間、空温で1時間撹拌して光学活性リチウムアセチ
リド(2′)に変換し、これを−78℃に冷却して上記
得られた(Si2−ベンジルオキシヘプタナール(3)
2.41g(4,4mmol)の無水テトラヒドロ
フラン20m1を滴下し、30分間更に撹拌した後、塩
化アンモニウム水溶液で分解し、エチルエーテルで3回
抽出して飽和食塩水で洗浄した後無水硫酸マグネシウム
で乾燥した。溶媒を減圧留去し、シリカゲルカラムクロ
マトグラフィー(エチルエーテル:ヘキサン=1:3(
容量))で精製して下記化学式(4)で表わされる(2
3.63)体の化合物3.81qを19だ(収率64%
)。このものはエリトロ体ニドレオ体−64: 36
(重量〉の混合物であった。6.2H1,CH) 4.51 (IH,d, J=11.6NZ,
CH) 4.65 (1t-f, d, J=11
.. 6Hz, CH)7.34 (5H,S,Ca
Hs) 9.64 (IH, d, J= 2.2
Hz) <Synthesis of compound (4)> (S)-dibromide 4.8 (1(16,
8 mmol) of anhydrous tetrahydrofuran (100 m)
Cool to 8°C and add 16.4 m of butyllithium-hexane solution with a concentration of 1.62 mol (26.6 m
mol> was added dropwise over 10 minutes, stirred for roughly 1 hour at -78°C and 1 hour at air temperature to convert it into optically active lithium acetylide (2'), which was then cooled to -78°C to obtain the above-mentioned product. (Si2-benzyloxyheptanal (3)
2.41 g (4.4 mmol) of anhydrous tetrahydrofuran (20 ml) was added dropwise, and after further stirring for 30 minutes, the mixture was decomposed with an aqueous ammonium chloride solution, extracted three times with ethyl ether, washed with saturated brine, and then dried over anhydrous magnesium sulfate. did. The solvent was distilled off under reduced pressure, and silica gel column chromatography (ethyl ether:hexane = 1:3 (
volume)) to produce (2
3.63) compound 3.81q is 19 (yield 64%)
). This one is erythro body Nidoreo body-64: 36
(weight) mixture.
(但し、Bnはベンジル基を表わす)
〈化合物(B)の合成〉
無水ジメチルスルホキシド680mg(8,7m mo
l >の無水塩化メチレン15m!溶液にオキザリルジ
クロリド0.38m(4゜4mmol>を−70℃で5
分間かけて滴下し、ざらに10分間同温度で撹拌した。(However, Bn represents a benzyl group) <Synthesis of compound (B)> 680 mg of anhydrous dimethyl sulfoxide (8.7 m mo
15 m of anhydrous methylene chloride! Add 0.38 m (4°4 mmol) of oxalyl dichloride to the solution at -70°C for 50 minutes.
The mixture was added dropwise over a period of minutes and stirred roughly for 10 minutes at the same temperature.
これに上記得られたエリトロ体ニドレオ体=64:36
の化合物(4) 1.00g(2,9mmol)の無
水塩化メチレン4dを滴下し9分間−70’Cで撹拌し
た。これに無水トリエチルアミン2.0m1(14m
mol>を滴下して徐々に空温に戻した後ヘキサンを加
え、セライト−545を通して濾過し、濾液を1規定塩
酸で洗浄した。水層を塩化メチレンで3回抽出し、抽出
物を飽和食塩水で洗浄し無水硫酸マグネシウムで乾燥し
た。溶媒を減圧留去し、シリカゲルカラムクロマトグラ
フィー(エチルエーテル:ヘキサン=1:10(容量)
)で精製し、下記化学式で示される(23.63>体の
エチニルケトン誘導体(B)550mqを得た(収率5
5%)。To this, the erythro body obtained above and the nidoleo body = 64:36
Compound (4) 1.00 g (2.9 mmol) of anhydrous methylene chloride 4d was added dropwise and stirred at -70'C for 9 minutes. To this was added 2.0 ml of anhydrous triethylamine (14 m
mol> was added dropwise and the temperature was gradually returned to air, then hexane was added and the mixture was filtered through Celite-545, and the filtrate was washed with 1N hydrochloric acid. The aqueous layer was extracted three times with methylene chloride, and the extract was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and subjected to silica gel column chromatography (ethyl ether:hexane=1:10 (volume)).
) to obtain 550 mq of the (23.63> ethynyl ketone derivative (B) shown in the following chemical formula (yield: 5
5%).
(但し、Bnはベンジル基を表わす)
IHNMR<CDα3)
δ:0.86 (3H,br t、 J= 7
.2Hz。(However, Bn represents a benzyl group) IHNMR<CDα3) δ: 0.86 (3H, br t, J= 7
.. 2Hz.
CH3)
1.0〜1.9 (8H,m、 CH2)1.38
(3H,S、CH3)1.47 (3H,
S、CH3)It、02 (IH,dd、 J
= 5.6H2゜8.24H2,CH)
418 (IH,dd、J= 6.4Hz。CH3) 1.0-1.9 (8H, m, CH2) 1.38
(3H,S,CH3)1.47 (3H,
S, CH3) It, 02 (IH, dd, J
= 5.6H2゜8.24H2, CH) 418 (IH, dd, J = 6.4Hz.
8.241−fz、 CH)
4.42 (IH,d、 J=11.5Hz、
CH)4.70 (IH,d、 J=11.5
H2,CH)4.86 (IH,dd、 J=
5.6Hz。8.241-fz, CH) 4.42 (IH, d, J=11.5Hz,
CH) 4.70 (IH, d, J=11.5
H2, CH) 4.86 (IH, dd, J=
5.6Hz.
6.4H2,CH)
7.31 (5H,S、 C6H5)IRνm
ax (neat)
695、 735. 835.1060.1220.1
320゜1370、1380.1450.1B75.2
200.2860゜2920、3020cm−1
〈化合物(A>の合成〉
上記得られた(23.63)体のエチニルケトン誘導体
(B) 550mg(1,6m mot)の無水エー
テル16d中へ一30℃で濃度0.26molの水素化
ホウ素亜鉛−エチルエーテル溶液9.6m (2,5m
mol )を窒素雰囲気下5分間かけて滴下し、ざら
に30分間撹拌した。反応終了後、水及び0.5規定塩
酸20m1を加え、0℃で30分間撹拌した。水層をエ
チルエーテルで3回抽出し、抽出液を飽和重曹水及び飽
和食塩水で順次洗浄し無水硫酸マグネシウムで乾燥した
。溶媒を減圧留去し、シリカゲルカラムクロマトグラフ
ィー(エチルエーテル:ヘキサン=1=3 (容量))
で精製して下記化学式で示される(23.5R,63)
体のエチニルアルコール誘導体(A) (エリトロ体ニ
ドレオ体=90:10(重量))349mOを得た(収
率63%)。6.4H2,CH) 7.31 (5H,S, C6H5)IRνm
ax (neat) 695, 735. 835.1060.1220.1
320°1370, 1380.1450.1B75.2
200.2860゜2920, 3020 cm-1 <Synthesis of compound (A>)> The ethynyl ketone derivative (B) of the (23.63) form obtained above was poured into 550 mg (1.6 m mot) of anhydrous ether 16d at -30°C. 9.6 m of zinc borohydride-ethyl ether solution with a concentration of 0.26 mol (2.5 m
mol) was added dropwise over 5 minutes under a nitrogen atmosphere, and the mixture was roughly stirred for 30 minutes. After the reaction was completed, water and 20 ml of 0.5N hydrochloric acid were added, and the mixture was stirred at 0°C for 30 minutes. The aqueous layer was extracted three times with ethyl ether, and the extract was washed successively with saturated aqueous sodium bicarbonate and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and subjected to silica gel column chromatography (ethyl ether:hexane=1=3 (volume))
It is purified by the following chemical formula (23.5R, 63)
349 mO of an ethynyl alcohol derivative (A) (erythro-nidoreo-isomer = 90:10 (weight)) was obtained (yield 63%).
(但し、Bnはベンジル基を表わす)
1HNMR(CDα3)
δ:0.87 (3H,br t、 J= 7
.2Hz。(However, Bn represents a benzyl group) 1HNMR (CDα3) δ: 0.87 (3H, br t, J= 7
.. 2Hz.
CH3)
1.0〜1.8 (8H,m、 CH2)1.36
(3H,S、 CH3)1.45
(3H,S、CH3>3.49 (IH,dt
、 J= 3.8Hz。CH3) 1.0-1.8 (8H, m, CH2) 1.36
(3H,S,CH3)1.45
(3H,S,CH3>3.49 (IH,dt
, J = 3.8Hz.
6.4H2,CH)
3.88 (1H,dd、J= 6.4H2゜7
.7H2,CH)
4゜12 (IH,dd、 J= 6.4Hz
。6.4H2, CH) 3.88 (1H, dd, J= 6.4H2゜7
.. 7H2, CH) 4゜12 (IH, dd, J= 6.4Hz
.
7.7NZ、 CH) 4.4〜4.7 (IH,m、 J= 1.5Hz。7.7NZ, CH) 4.4-4.7 (IH, m, J = 1.5Hz.
3.8Hz、 CH)
4.59 (2H,S、CH2)4.69
(IH,ddd、 J= 1.5tlz。3.8Hz, CH) 4.59 (2H, S, CH2) 4.69
(IH, ddd, J= 1.5tlz.
6.4H2,6,4H2,CH)
7.30 (5H,S、 C6H5)13CNM
R(CDC13)
δ: 13.98. 22.54. 25.27.
25゜96. 26.22゜30.06. 31.85
. 64.1B、 65.57. 69.94゜72
.49. f31.50. 83.70. 84.0
0.100.31゜127.83.128.40.13
8.21上記得られた本発明の目的物であるエチニルア
ルコール誘導体(A)を用いて、以下の例に従ってプロ
スタグランジン合成のための鍵中間体である前記−殺伐
(P)で表わされる光学活性T−ラクトン誘導体を合成
した。6.4H2,6,4H2,CH) 7.30 (5H,S, C6H5)13CNM
R(CDC13) δ: 13.98. 22.54. 25.27.
25°96. 26.22゜30.06. 31.85
.. 64.1B, 65.57. 69.94°72
.. 49. f31.50. 83.70. 84.0
0.100.31゜127.83.128.40.13
8.21 Using the above-obtained ethynyl alcohol derivative (A), which is the object of the present invention, the optical compound represented by the above-described (P), which is a key intermediate for prostaglandin synthesis, according to the following example. An active T-lactone derivative was synthesized.
〈化合物(5)の合成〉
上記得られた(2S、 5R,63)体のエチニルアル
コール誘導体(A) 105mg(0,30m mo
l>の無水テトラヒドロフラン2d溶液を水素化リチウ
ムアルミニウム24.1m(] (00,63mmol
>の無水テトラヒドロフラン5I7112中に0℃で
加え、18分間撹拌還流した。反応終了後、酢酸エチル
、エタノール、水、0.1規定塩酸を順次加えて分解し
、水層をエチルエーテルで2回抽出した。抽出液を飽和
食塩水で洗浄し、無水硫酸マグネシウムで乾燥後、溶媒
を減圧留去し、シリカゲルカラムクロマトグラフィー(
エチルエーテル:ヘキサン=1:3(容量))で精製し
て下記化学式で示される(23.5R,63)体のアリ
ルアルコール誘導体(5) 80.1mC1を得たく収
率76%)。<Synthesis of compound (5)> 105 mg (0,30 m mo
A 2d solution of anhydrous tetrahydrofuran of
> of anhydrous tetrahydrofuran 5I7112 at 0°C, and the mixture was stirred and refluxed for 18 minutes. After the reaction was completed, ethyl acetate, ethanol, water, and 0.1N hydrochloric acid were sequentially added for decomposition, and the aqueous layer was extracted twice with ethyl ether. The extract was washed with saturated brine, dried over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, and silica gel column chromatography (
Ethyl ether:hexane=1:3 (volume)) to obtain the (23.5R,63) allyl alcohol derivative (5) 80.1 mC1 represented by the following chemical formula (yield: 76%).
(但し、Bnはベンジル基を表わす)
1HNMR(CDα3)
δ:0.86 (3H,t、 J= 5.4.H
2゜CH3)
1.38 (3H,S、CH3)1.40
(3H,S、CH3>1.04〜1.8 (8H,
m、 CH2)3.2〜3.5 (IH,m、CH)
3.52 (IH,dd、 J= 7.7Hz。(However, Bn represents a benzyl group) 1HNMR (CDα3) δ: 0.86 (3H, t, J = 5.4.H
2゜CH3) 1.38 (3H, S, CH3) 1.40
(3H, S, CH3>1.04~1.8 (8H,
m, CH2) 3.2-3.5 (IH, m, CH)
3.52 (IH, dd, J= 7.7Hz.
7.7tiZ、 CH)
4.08 (1H,dd、 J= 6.4H2゜
8、OH2,CH)
+3ONMR(CDα3)
δ: 14.02. 22.61. 25.46.
25.92. 26.72゜29.42. 31.93
. 69.44. 72.22. 72.5B。7.7tiZ, CH) 4.08 (1H, dd, J= 6.4H2°8, OH2, CH) +3ONMR (CDα3) δ: 14.02. 22.61. 25.46.
25.92. 26.72°29.42. 31.93
.. 69.44. 72.22. 72.5B.
’82.18.127.72.127.79.128.
40.129.89゜132.47.140.60
〈化合物く6)の合成〉
上記17られた(23.5R,68)体のアリルアルコ
ール誘導体(5) 80.1m(] (00,23mf
f1ol > 、トリニブルオルトアセデート0.15
m1(0,82m mol )及び触媒但のヘプタノイ
ックアシッドをキシレン3d中160℃で20分間加熱
反応させ、キシレンと生成したエタノールを減圧留去し
、反応終了後飽和重曹水で分解した。水層をエチルエー
テルで2回抽出し、抽出物を飽和食塩水で洗浄した後無
水硫酸マグネシウムで乾燥した。溶rs@減圧留去後、
シリカゲルカラムクロマトグラフィー(エチルエーテル
:ヘキサン=1:、10(容量))で精製して下記化学
式で示される( 1’S、 33.63>体のγ−不飽
和カルボン酸エチル(6) 65.6m(lを得た(収
率68%)。'82.18.127.72.127.79.128.
40.129.89゜132.47.140.60 <Synthesis of compound 6)> Allyl alcohol derivative (5) of the (23.5R,68) form obtained in 17 above 80.1m(] (00,23mf
f1ol>, trinible orthoacedate 0.15
m1 (0.82 mmol) and heptanoic acid as a catalyst were heated and reacted in xylene 3d at 160° C. for 20 minutes, the xylene and the produced ethanol were distilled off under reduced pressure, and after the reaction was completed, the mixture was decomposed with saturated sodium bicarbonate water. The aqueous layer was extracted twice with ethyl ether, and the extract was washed with saturated brine and dried over anhydrous magnesium sulfate. After removing the solution under reduced pressure,
It was purified by silica gel column chromatography (ethyl ether:hexane = 1:, 10 (volume)) to obtain ethyl γ-unsaturated carboxylate (6) of the following chemical formula (1'S, 33.63>) 65. 6 m(l) was obtained (yield 68%).
(6)
(但し、Bnはベンジル基を表わす)
IHNMR(CDα3)
δ:0.8& (3H,br t、 J= 7
.2Hz。(6) (However, Bn represents a benzyl group) IHNMR (CDα3) δ: 0.8 & (3H, br t, J= 7
.. 2Hz.
CH3)
1.0〜1.8 (8H,m、 CH2)1.33
、 (3H,S、CH3)1.44 (3H
,S、CH3)2.40 (IH,dd
、 J= 9.0tlz。CH3) 1.0-1.8 (8H, m, CH2) 1.33
, (3H,S,CH3)1.44 (3H
,S,CH3)2.40 (IH,dd
, J=9.0tlz.
14.7Hz、 Cf−1>
2.50 (IH,dd、J= 5.1112゜
14.7H2,CH)
2.6〜3.0 (It−(、m、 CH)3.5〜
3.8 (2日、 m、 CH2)3.9〜4.3
(2H,m、CHX2 )4.09 (
2H,q、 J= 7.2H2゜CH20)
4.31 (1)−1,d、 J=I
L7tlz。14.7Hz, Cf-1> 2.50 (IH, dd, J= 5.1112°14.7H2, CH) 2.6~3.0 (It-(, m, CH) 3.5~
3.8 (2 days, m, CH2) 3.9-4.3
(2H,m,CHX2)4.09 (
2H, q, J= 7.2H2゜CH20) 4.31 (1)-1, d, J=I
L7tlz.
CH208H5> 4.55 (IH,d、 J=11.7Hz。CH208H5> 4.55 (IH, d, J = 11.7Hz.
CH2C6H5)
5.2 〜5.7 (2H,m、 =CH−)7
.27 (5H,S、 C6ト15
)13ONMR(CDC13)
δ: 14.00. 14.25. 22.59.
25.03. 2B、30゜31.77、 35.72
. 36.50. 41.77、 60.32゜66.
81. 69.79. 77.30. 79.74.1
09.08゜127.28.127.72.128.2
0.130.84.134.45゜139.00.17
1.79
〈化合物(P)の合成〉
上記得られた(1°S、 33.63)体のγ−不飽和
カルボン酸エエチ(6) 65mg(0,16m mo
l> 、メタノール5r1111水1.25m及びCu
SO4・5820186mg(0,75m mol)を
13時間撹拌還流した。反応終了後、エチルエーテルを
加えてセライト−545により濾過し、濾液を飽和食塩
水で洗浄した後無水硫酸マグネシウムで乾燥した。溶媒
を減圧留去後、シリカゲルカラムクロマトグラフィー(
酢酸エチル:ヘキサジ=1:5(容量))で精製して下
記化学式で示される(33. 3°S、 43)体のγ
−ラクトン誘導体(p)35.5…Qを得た(収率69
%)。CH2C6H5) 5.2 ~ 5.7 (2H, m, =CH-)7
.. 27 (5H, S, C6 to 15
)13ONMR (CDC13) δ: 14.00. 14.25. 22.59.
25.03. 2B, 30°31.77, 35.72
.. 36.50. 41.77, 60.32°66.
81. 69.79. 77.30. 79.74.1
09.08°127.28.127.72.128.2
0.130.84.134.45゜139.00.17
1.79 <Synthesis of compound (P)> 65 mg (0.16 m mo
l>, methanol 5r1111 water 1.25m and Cu
SO4.5820186 mg (0.75 mmol) was stirred and refluxed for 13 hours. After the reaction was completed, ethyl ether was added and the mixture was filtered through Celite-545. The filtrate was washed with saturated brine and dried over anhydrous magnesium sulfate. After removing the solvent under reduced pressure, silica gel column chromatography (
Ethyl acetate:hexadi=1:5 (volume)
-Lactone derivative (p) 35.5...Q was obtained (yield 69
%).
Bn
(但し、Bnはベンジル基を表わす)
’t−INMR(CD(J3)
δ:0.88 (3H,br t、 J= 7
.2H2゜CH3)
1.0 〜1.8 (8H,m、 CH2)3.
72〜3.9 (5H,m、 CH2、Cl−1
>4.4 〜4.7 (IH,m、 CI−(>4
.36 (IH,d、 J=11.7H2゜C
H2)
4.51 (IH,d、 J=11.7Hz。Bn (However, Bn represents a benzyl group) 't-INMR (CD (J3) δ: 0.88 (3H, br t, J = 7
.. 2H2°CH3) 1.0 to 1.8 (8H, m, CH2)3.
72-3.9 (5H, m, CH2, Cl-1
>4.4 ~4.7 (IH, m, CI-(>4
.. 36 (IH, d, J=11.7H2゜C
H2) 4.51 (IH, d, J=11.7Hz.
CH2)
5.55 (IH,dd、 J= 6.7H
2゜15.4H2,=CH)
5.68 (IH,dd、J= 7.7H2゜1
5.4H2,=CH)
7.29 (’5H,S、 C8H5)13 C
NMR(CDQ!3 )
δ: 14.00. 22.57. 24.98.
31.89. 34.94゜41.02. 62.27
. 70.42. 79.50. 82.60゜127
.52.127.62.128.23.135.62.
138.63゜176.48
(発明の効果)
本発明の光学活性化合物は、プロスタグランジンを合成
する際の鍵中間体となる光学活性γ−ラクトン誘導体製
造のための原料として重要な化合物でおり、この化合物
を用いることにより比較的簡便に、効率よく鍵中間体が
製造できる。CH2) 5.55 (IH, dd, J= 6.7H
2゜15.4H2,=CH) 5.68 (IH, dd, J= 7.7H2゜1
5.4H2,=CH) 7.29 ('5H,S, C8H5)13C
NMR (CDQ!3) δ: 14.00. 22.57. 24.98.
31.89. 34.94°41.02. 62.27
.. 70.42. 79.50. 82.60°127
.. 52.127.62.128.23.135.62.
138.63゜176.48 (Effects of the Invention) The optically active compound of the present invention is an important compound as a raw material for the production of optically active γ-lactone derivatives, which are key intermediates in prostaglandin synthesis. By using this compound, the key intermediate can be produced relatively easily and efficiently.
Claims (1)
していてもよいアルキル基、シクロアルキル基及び芳香
環もしくはアルキル基にヘテロ原子を有するアラルキル
基から選ばれた炭素数1〜12の基、R^2は水素原子
又はアシル基、シリル基、アラルキル基及びアルキルオ
キシアルキル基から選ばれた容易に脱離可能な保護基を
表わし、*の符号は不斉炭素原子を表わす。 (2)一般式(A)のR^1が炭素数4〜10のアルキ
ル基である請求項1記載の光学活性化合物。 (3)アルキル基がペンチル基である請求項2記載の光
学活性化合物。 (4)一般式(A)のR^2がアラルキル基である請求
項1〜3いずれかに記載の光学活性化合物。 (5)アラルキル基がベンジル基である請求項4記載の
光学活性化合物。 (6)一般式(A)の化合物が光学活性(2S、5R、
6S)体である請求項1〜5いずれかに記載の化合物。 (7)下記一般式(A) ▲数式、化学式、表等があります▼(A) (上記一般式(A)において、R^1はアルコキシ基を
有していてもよいアルキル基、シクロアルキル基及び芳
香環もしくはアルキル基にヘテロ原子を有するアラルキ
ル基から選ばれた炭素数1〜12の基、R^2は水素原
子又はアシル基、シリル基、アラルキル基及びアルキル
オキシアルキル基から選ばれた容易に脱離可能な保護基
を表わし、*の符号は不斉炭素原子を表わす)で表わさ
れる光学活性化合物を製造するにあたり、下記一般式(
B) ▲数式、化学式、表等があります▼(B) (上記一般式(B)において、R^1、R^2及び*の
符号は一般式(A)のR^1、R^2及び*の符号と同
じ意味を表わす) で表わされる光学活性化合物をアルカリ金属セレクトリ
ド又は水素化ホウ素金属錯体で還元することを特徴とす
る光学活性化合物の製法。 (8)一般式(A)のR^1が炭素数4〜10のアルキ
ル基である請求項7記載の製法。(9)アルキル基がペ
ンチル基である請求項8記載の製法。 (10)一般式(A)のR^2がアラルキル基である請
求項7〜9いずれかに記載の製法。 (11)アラルキル基がベンジル基である請求項10記
載の製法。 (12)一般式(A)の化合物が光学活性(2S、5R
、6S)体である請求項7〜11いずれかに記載の製法
。[Scope of Claims] (1) An optically active compound represented by the following general formula (A). ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (A) In the above general formula (A), R^1 is an alkyl group that may have an alkoxy group, a cycloalkyl group, an aromatic ring, or a hetero atom in the alkyl group. a group having 1 to 12 carbon atoms selected from aralkyl groups, R^2 represents a hydrogen atom or an easily removable protecting group selected from acyl groups, silyl groups, aralkyl groups and alkyloxyalkyl groups, The symbol * represents an asymmetric carbon atom. (2) The optically active compound according to claim 1, wherein R^1 in general formula (A) is an alkyl group having 4 to 10 carbon atoms. (3) The optically active compound according to claim 2, wherein the alkyl group is a pentyl group. (4) The optically active compound according to any one of claims 1 to 3, wherein R^2 in general formula (A) is an aralkyl group. (5) The optically active compound according to claim 4, wherein the aralkyl group is a benzyl group. (6) The compound of general formula (A) has optical activity (2S, 5R,
6S) compound according to any one of claims 1 to 5. (7) The following general formula (A) ▲ Numerical formulas, chemical formulas, tables, etc. are included ▼ (A) (In the above general formula (A), R^1 is an alkyl group that may have an alkoxy group, a cycloalkyl group and a group having 1 to 12 carbon atoms selected from aralkyl groups having a heteroatom in an aromatic ring or an alkyl group, R^2 is a hydrogen atom or a group selected from an acyl group, a silyl group, an aralkyl group, and an alkyloxyalkyl group. When producing an optically active compound represented by the formula (representing a protective group that can be removed by
B) ▲There are mathematical formulas, chemical formulas, tables, etc.▼(B) (In the above general formula (B), the signs of R^1, R^2 and * are the same as R^1, R^2 and * of general formula (A). 1. A method for producing an optically active compound, which comprises reducing an optically active compound represented by the following symbol * with an alkali metal selectride or a borohydride metal complex. (8) The method according to claim 7, wherein R^1 in general formula (A) is an alkyl group having 4 to 10 carbon atoms. (9) The method according to claim 8, wherein the alkyl group is a pentyl group. (10) The method according to any one of claims 7 to 9, wherein R^2 in general formula (A) is an aralkyl group. (11) The method according to claim 10, wherein the aralkyl group is a benzyl group. (12) The compound of general formula (A) has optical activity (2S, 5R
, 6S) is the production method according to any one of claims 7 to 11.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1140796A JPH0651691B2 (en) | 1989-06-01 | 1989-06-01 | Optically active compound |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1140796A JPH0651691B2 (en) | 1989-06-01 | 1989-06-01 | Optically active compound |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5293226A Division JP2785658B2 (en) | 1993-11-24 | 1993-11-24 | Preparation of optically active compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH035472A true JPH035472A (en) | 1991-01-11 |
| JPH0651691B2 JPH0651691B2 (en) | 1994-07-06 |
Family
ID=15276944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1140796A Expired - Lifetime JPH0651691B2 (en) | 1989-06-01 | 1989-06-01 | Optically active compound |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0651691B2 (en) |
-
1989
- 1989-06-01 JP JP1140796A patent/JPH0651691B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0651691B2 (en) | 1994-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0362816B1 (en) | Cyclopenteneheptanoic acid derivatives and method of preparation thereof | |
| EP0585104B1 (en) | A method of preparing a saturated monocyclic hydrocarbon compound and an intermediate therefor | |
| JP2743797B2 (en) | Preparation of optically active compounds | |
| JPH035472A (en) | Optically active compound and its production | |
| JP2785657B2 (en) | Preparation of optically active compounds | |
| JPH035470A (en) | Production of optically active gamma-lactone derivative | |
| JP2785658B2 (en) | Preparation of optically active compounds | |
| JP2743798B2 (en) | Preparation of optically active compounds | |
| JPH035474A (en) | Optically active compound and its production | |
| JP4598429B2 (en) | Dihalogenated prostacyclins | |
| US4133818A (en) | Process for producing lactones | |
| US5087703A (en) | Process for synthesis of FK-506 intermediates | |
| JP3692553B2 (en) | Method for producing difluorolactones | |
| US5198588A (en) | Optically active isoxazole derivatives and intermediates for preparation thereof | |
| JP2654835B2 (en) | Optically active 4-en-6-ol compounds, intermediates for their production and methods for their production | |
| EP0103445A2 (en) | Process for production of prostaglandins E or F, and novel 7-(thiocarbo-acyloxy) prostaglandins E or F | |
| US5266703A (en) | Optically active isoxazole derivatives | |
| JP2731013B2 (en) | 11-Epiisocarbacyclines and method for producing the same | |
| US5220074A (en) | Optically active isoxazole derivatives and intermediates for preparation thereof as well as processes for producing the same | |
| JP4000599B2 (en) | Substituted cyclopentene derivatives and process for producing the same | |
| JPS5944336A (en) | Novel preparation of 2-allylcyclopentanones | |
| JPS5929587B2 (en) | Method for producing phenyl-substituted PGE↓ type 2 compounds | |
| JPS6254789B2 (en) | ||
| JPH0660155B2 (en) | Isocarbacyclines | |
| JPH03176449A (en) | Optically active 2-methylenepentanal derivative |